Production (Stage)
Ensysce Biosciences, Inc.
ENSC
$2.07
-$0.07-3.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.95M | -3.56M | 661.80K | -1.97M | -3.12M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 25.70K | 1.17M |
| Total Other Non-Cash Items | 55.40K | 47.80K | 18.50K | 20.60K | 51.80K |
| Change in Net Operating Assets | 182.80K | 2.75M | -1.70M | -388.40K | -1.51M |
| Cash from Operations | -1.71M | -764.10K | -1.02M | -2.31M | -3.41M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -47.20K | -96.30K | -71.40K | -51.20K | -638.90K |
| Issuance of Common Stock | 1.45M | 357.90K | 1.67M | 0.00 | 2.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -143.00K | -149.00K | 2.53M | 0.00 | 4.25M |
| Cash from Financing | 1.26M | 112.60K | 4.13M | -51.20K | 5.69M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -449.60K | -651.50K | 3.11M | -2.36M | 2.28M |